000908 ST景峰醫藥
按盤價 
5.560 -0.170 (-2.967%)
5.560 -0.170 (-2.967%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -49.703 | 2,684.856 | -500.552 | -54.114 | -43.523 |
| 總資產報酬率 ROA (%) | -3.532 | 15.228 | -18.754 | -7.585 | -6.887 |
| 投入資產回報率 ROIC (%) | -5.497 | 23.837 | -30.059 | -11.048 | -9.446 | 邊際利潤分析 |
| 銷售毛利率 (%) | 65.326 | 62.800 | 71.758 | 76.288 | 62.087 |
| 營業利潤率 (%) | -13.761 | 49.004 | -26.322 | -8.127 | -15.401 |
| 息稅前利潤/營業總收入 (%) | -9.143 | 49.229 | -23.423 | -4.084 | -7.205 |
| 淨利潤/營業總收入 (%) | -17.549 | 38.326 | -34.626 | -11.331 | -23.506 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 90.211 | -31.535 | 69.975 | 58.938 | 249.946 |
| 價值變動淨收益/利潤總額(%) | 1.239 | 159.891 | -14.854 | -16.140 | -177.348 |
| 營業外收支淨額/利潤總額(%) | 18.761 | -23.915 | 11.156 | 20.220 | 13.530 | 償債能力分析 |
| 流動比率 (X) | 0.192 | 0.251 | 0.205 | 0.527 | 0.498 |
| 速動比率 (X) | 0.139 | 0.202 | 0.143 | 0.416 | 0.384 |
| 資產負債率 (%) | 105.228 | 101.610 | 116.470 | 86.166 | 82.557 |
| 帶息債務/全部投入資本 (%) | 81.246 | 78.673 | 92.295 | 70.987 | 70.087 |
| 股東權益/帶息債務 (%) | 10.725 | 16.776 | -11.598 | 25.432 | 31.484 |
| 股東權益/負債合計 (%) | 5.177 | 8.564 | -5.705 | 13.121 | 19.678 |
| 利息保障倍數 (X) | -1.173 | 5.084 | -3.775 | -0.669 | -0.679 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 63.595 | 60.091 | 67.168 | 79.197 | 143.424 |
| 存貨周轉天數 (天) | 129.270 | 126.489 | 179.444 | 249.019 | 226.966 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 27/08/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
